Cargando…
Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic disease with a high symptom burden and poor survival that influences patients’ health-related quality of life (HRQOL). We aimed to evaluate IPF patients’ symptoms and HRQOL in a well-documented clinical cohort during their last two years o...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247520/ https://www.ncbi.nlm.nih.gov/pubmed/30458739 http://dx.doi.org/10.1186/s12890-018-0738-x |
_version_ | 1783372492324208640 |
---|---|
author | Rajala, K. Lehto, J. T. Sutinen, E. Kautiainen, H. Myllärniemi, M. Saarto, T. |
author_facet | Rajala, K. Lehto, J. T. Sutinen, E. Kautiainen, H. Myllärniemi, M. Saarto, T. |
author_sort | Rajala, K. |
collection | PubMed |
description | BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic disease with a high symptom burden and poor survival that influences patients’ health-related quality of life (HRQOL). We aimed to evaluate IPF patients’ symptoms and HRQOL in a well-documented clinical cohort during their last two years of life. METHODS: In April 2015, we sent the Modified Medical Research Council Dyspnea Scale (MMRC), the modified Edmonton Symptom Assessment Scale (ESAS) and a self-rating HRQOL questionnaire (RAND-36) to 300 IPF patients, of which 247 (82%) responded. Thereafter, follow-up questionnaires were sent every six months for two years. RESULTS: Ninety-two patients died by August 2017. Among these patients, HRQOL was found to be considerably low already two years before death. The most prominent declines in HRQOL occurred in physical function, vitality, emotional role and social functioning (p < 0.001). The proportion of patients with MMRC scores ≥3 increased near death. Breathlessness and fatigue were the most severe symptoms. Symptom severity for the following symptoms increased significantly and reached the highest mean scores during the last six months of life (numeric rating scale/standard deviation): breathlessness (7.1/2.8), tiredness (7.0/2.3), dry mouth (6.0/3.0), cough (5.8/2.9), and pain with movement (5.0/3.5). CONCLUSIONS: To our knowledge this is the first study demonstrating, that IPF patients experience remarkably low HRQOL already two years before death, especially regarding physical role. In addition, they suffer from severe breathlessness and fatigue. Furthermore, physical, social and emotional wellbeing deteriorate, and symptom burden increases near death. Regular symptom and HRQOL measurements are essential to assess palliative care needs in patients with IPF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12890-018-0738-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6247520 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62475202018-11-26 Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life Rajala, K. Lehto, J. T. Sutinen, E. Kautiainen, H. Myllärniemi, M. Saarto, T. BMC Pulm Med Research Article BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic disease with a high symptom burden and poor survival that influences patients’ health-related quality of life (HRQOL). We aimed to evaluate IPF patients’ symptoms and HRQOL in a well-documented clinical cohort during their last two years of life. METHODS: In April 2015, we sent the Modified Medical Research Council Dyspnea Scale (MMRC), the modified Edmonton Symptom Assessment Scale (ESAS) and a self-rating HRQOL questionnaire (RAND-36) to 300 IPF patients, of which 247 (82%) responded. Thereafter, follow-up questionnaires were sent every six months for two years. RESULTS: Ninety-two patients died by August 2017. Among these patients, HRQOL was found to be considerably low already two years before death. The most prominent declines in HRQOL occurred in physical function, vitality, emotional role and social functioning (p < 0.001). The proportion of patients with MMRC scores ≥3 increased near death. Breathlessness and fatigue were the most severe symptoms. Symptom severity for the following symptoms increased significantly and reached the highest mean scores during the last six months of life (numeric rating scale/standard deviation): breathlessness (7.1/2.8), tiredness (7.0/2.3), dry mouth (6.0/3.0), cough (5.8/2.9), and pain with movement (5.0/3.5). CONCLUSIONS: To our knowledge this is the first study demonstrating, that IPF patients experience remarkably low HRQOL already two years before death, especially regarding physical role. In addition, they suffer from severe breathlessness and fatigue. Furthermore, physical, social and emotional wellbeing deteriorate, and symptom burden increases near death. Regular symptom and HRQOL measurements are essential to assess palliative care needs in patients with IPF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12890-018-0738-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-20 /pmc/articles/PMC6247520/ /pubmed/30458739 http://dx.doi.org/10.1186/s12890-018-0738-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Rajala, K. Lehto, J. T. Sutinen, E. Kautiainen, H. Myllärniemi, M. Saarto, T. Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life |
title | Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life |
title_full | Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life |
title_fullStr | Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life |
title_full_unstemmed | Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life |
title_short | Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life |
title_sort | marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247520/ https://www.ncbi.nlm.nih.gov/pubmed/30458739 http://dx.doi.org/10.1186/s12890-018-0738-x |
work_keys_str_mv | AT rajalak markeddeteriorationinthequalityoflifeofpatientswithidiopathicpulmonaryfibrosisduringthelasttwoyearsoflife AT lehtojt markeddeteriorationinthequalityoflifeofpatientswithidiopathicpulmonaryfibrosisduringthelasttwoyearsoflife AT sutinene markeddeteriorationinthequalityoflifeofpatientswithidiopathicpulmonaryfibrosisduringthelasttwoyearsoflife AT kautiainenh markeddeteriorationinthequalityoflifeofpatientswithidiopathicpulmonaryfibrosisduringthelasttwoyearsoflife AT myllarniemim markeddeteriorationinthequalityoflifeofpatientswithidiopathicpulmonaryfibrosisduringthelasttwoyearsoflife AT saartot markeddeteriorationinthequalityoflifeofpatientswithidiopathicpulmonaryfibrosisduringthelasttwoyearsoflife |